Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

Benha University

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Irvine-Gass Syndrome; Central Serous Chorioretinopathy; Cystoid Macular Edema; Pars Planitis

Treatments: Drug: Triamcinolone Acetonide

Study type: Interventional

Funder types: Other

Identifiers

NCT05337332

RC 7-7-22

Details and patient eligibility

About

Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.

Full description

Suprachoroidal triamcinolone acetonide injection is used to treat various retinal diseases, higher concentration of the injected material is found when the suprachoroidal space is used as an intraocular delivery pathway when compared to the conventional intravitreal pathway.

Enrollment: 50 estimated patients

Sex: All

Ages: 20 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery.

Exclusion criteria

• other retinal diseases that may affect CMT and final visual outcome.
• Patients with dense corneal opacity.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Central serous chorioretinopathy group

Experimental group

Description:

Cases with central serous chorioretinopathy (CSR) that will be injected with suprachoroidal triamcinolone acetonide.

Treatment:

Drug: Triamcinolone Acetonide

Irvine-Gass Syndrome group

Experimental group

Description:

Cases with cystoid macular edema due to irvine-gass syndrome that will be injected with suprachoroidal triamcinolone acetonide

Treatment:

Drug: Triamcinolone Acetonide